About the Product

Description


Paroxyle 37.5 mg CR Tablet contains Paroxetine, a widely prescribed antidepressant used for the treatment of depression, anxiety disorders, panic attacks, and mood-related conditions. It helps improve emotional stability and enhances overall mental well-being.

Paroxetine works by selectively inhibiting the reuptake of serotonin in the brain, which plays a key role in regulating mood and behavior. The controlled release formulation ensures gradual drug delivery, providing sustained therapeutic action and improved patient compliance.

This medicine is commonly used in psychiatric treatment plans for long-term management of mental health conditions. Its effectiveness in reducing symptoms such as stress, anxiety, and depressive episodes makes it a preferred choice among healthcare professionals.

With rising awareness about mental health and increasing demand for psychiatric medicines, this product offers strong market potential. Its consistent prescription demand, long-term usage, and growing acceptance make it a reliable option for expanding business in the neuro and psychiatry segment.

Some patients may experience nausea, dizziness, dry mouth, insomnia or drowsiness, and sexual dysfunction. Other possible effects include sweating, weakness, or changes in appetite and weight. In rare cases, mood changes or suicidal thoughts may occur, particularly during the early stages of therapy.

Paroxyle 37.5 mg CR Tablet (Paroxetine 37.5 mg) is indicated for the treatment of depression, generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, and obsessive-compulsive disorder (OCD). It helps stabilize mood, reduce anxiety, control panic episodes, and improve overall mental well-being.

This medication should be taken strictly under medical supervision. Do not discontinue abruptly, as it may lead to withdrawal symptoms. Dose adjustments should be made only by a healthcare professional. Avoid alcohol and inform your doctor about any ongoing medications or medical conditions.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep in the original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Paroxyle 37.5mg CR Tablet in the PCD pharma franchise market?

Paroxyle 37.5mg CR Tablet, containing Paroxetine 37.5mg (controlled release), has strong demand in the neuropsychiatry and antidepressant segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on CNS and mental health portfolios.

Why should medical distributors include Paroxyle 37.5mg CR Tablet in their product range?

Medical distributors and agencies can benefit from the consistent market demand for medicines used in depression, anxiety disorders, panic disorders, and other psychiatric conditions. Paroxyle 37.5mg CR Tablet helps strengthen a comprehensive neuropsychiatry product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Paroxyle 37.5mg CR Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Paroxyle 37.5mg CR Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Paroxyle 37.5mg CR Tablet distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted CNS and antidepressant product range when partnering for Paroxyle 37.5mg CR Tablet distribution.

How can I become a distributor or franchise partner for Paroxyle 37.5mg CR Tablet?

Medical distributors, stockists, and wholesalers interested in Paroxyle 37.5mg CR Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.